Hassman Research Institutes
Berlin, New Jersey 08009
0 studies enrolling now · 1 studies all time
What they study most
Episodic Migraine
Studies at this site
Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine
— Completed